CNS Neuroscience & Therapeutics,
Journal Year:
2023,
Volume and Issue:
29(S1), P. 59 - 73
Published: Jan. 4, 2023
Abstract
Background
Diabetic
cognitive
dysfunction
(DCD)
is
one
of
the
most
insidious
complications
type
2
diabetes
mellitus,
which
can
seriously
affect
ability
to
self‐monitoring
blood
glucose
and
quality
life
in
elderly.
Previous
pathological
studies
have
focused
on
neuronal
dysfunction,
characterized
by
extracellular
beta‐amyloid
deposition
intracellular
tau
hyperphosphorylation.
In
recent
years,
astrocytes
been
recognized
as
a
potential
therapeutic
target
for
important
participants
central
control
metabolism.
The
disorder
gut
microbiota
their
metabolites
linked
series
metabolic
diseases
such
mellitus.
imbalance
intestinal
flora
has
effect
promoting
occurrence
deterioration
several
diabetes‐related
complications.
Gut
microbes
drive
astrocyte
activation.
Aims
We
reviewed
progress
DCD
related
“gut
microbiota‐astrocyte”
axis
terms
peripheral
inflammation,
blood–brain
barrier
(BBB)
systemic
brain
energy
metabolism
disorders
deepen
research
explore
targets.
Conclusion
“Gut
axis,
unique
bidirectional
crosstalk
brain‐gut
mediates
intermediate
process
neurocognitive
secondary
Cardiovascular Diabetology,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: Jan. 19, 2022
Abstract
Background
Diabetes
and
hypertension
are
common
in
older
adults
represent
established
risk
factors
for
frailty.
Frailty
is
a
multidimensional
condition
due
to
reserve
loss
susceptibility
stressors
with
high
of
death,
hospitalizations,
functional
cognitive
impairment.
Comorbidities
such
as
diabetes
play
key
role
increasing
the
mortality,
hospitalization,
disability.
Moreover,
frail
patients
known
have
an
increased
physical
Nevertheless,
no
study
assessed
correlation
between
impairment
hypertension.
Methods
We
evaluated
consecutive
who
presented
at
ASL
(local
health
unit
Italian
Ministry
Health)
Avellino,
Italy,
from
March
2021
October
2021.
The
inclusion
criteria
were:
previous
diagnosis
evidence
secondary
causes;
age
>
65
years;
frailty
status;
Montreal
Cognitive
Assessment
(MoCA)
score
<
26.
Results
179
successfully
completed
study.
found
strong
significant
MoCA
5-m
gait
speed
test
(r:
0.877;
p
0.001).
To
further
verify
our
results,
we
performed
linear
multivariate
analysis
adjusting
potential
confounding
factors,
dependent
variable,
which
confirmed
association
glycemia
(p
Conclusions
This
first
showing
diabetic
hypertensive
adults.
American Journal of Lifestyle Medicine,
Journal Year:
2022,
Volume and Issue:
16(3), P. 342 - 362
Published: May 1, 2022
Objective:
The
objective
of
this
Expert
Consensus
Statement
is
to
assist
clinicians
in
achieving
remission
type
2
diabetes
(T2D)
adults
using
diet
as
a
primary
intervention.
Evidence-informed
statements
agreed
upon
by
multi-disciplinary
panel
expert
healthcare
professionals
were
used.
Methods:
Panel
members
with
expertise
treatment,
research,
and
followed
an
established
methodology
for
developing
consensus
modified
Delphi
process.
A
search
strategist
systematically
reviewed
the
literature,
best
available
evidence
was
used
compose
regarding
dietary
interventions
18
years
older
diagnosed
T2D.
Topics
significant
practice
variation
those
that
would
result
T2D
prioritized.
Using
iterative,
online
process,
expressed
levels
agreement
statements,
resulting
classification
consensus,
near-consensus,
or
non-consensus
based
on
mean
responses
number
outliers.
Results:
identified
131
candidate
focused
addressing
following
high-yield
topics:
(1)
definitions
basic
concepts;
(2)
T2D;
(3)
specifics
types
diets;
(4)
adjuvant
alternative
interventions;
(5)
support,
monitoring,
adherence
therapy;
(6)
weight
loss;
(7)
payment
policy.
After
4
iterations
survey
removal
duplicative
69
met
criteria
5
designated
near
60
no
consensus.
In
addition,
reached
key
issues:
(a)
Remission
should
be
defined
HbA1c
<6.5%
at
least
3
months
surgery,
devices,
active
pharmacologic
therapy
specific
purpose
lowering
blood
glucose;
(b)
intervention
can
achieve
many
related
intensity
intervention;
(c)
most
effective
when
emphasizing
whole,
plant-based
foods
minimal
consumption
meat
other
animal
products.
Many
additional
achieved
are
highlighted
tabular
presentation
manuscript
elaborated
discussion
section.
Conclusion:
pertaining
T2D,
diets,
interventions,
therapy,
loss,
Clinicians
use
these
improve
quality
care,
inform
policy
protocols,
identify
areas
uncertainty.
Conectando Pessoas eBooks,
Journal Year:
2022,
Volume and Issue:
unknown
Published: Jan. 1, 2022
Em
pacientes
com
diabetes,
o
controle
glicêmico
deve
ser
individualizado
de
acordo
a
situação
clínica.Os
parâmetros
avaliação
indicados
são
hemoglobina
glicada
A1c
(HbA1c)
e
as
glicemias
capilares
(ou
plasmáticas)
determinadas
em
jejum,
nos
períodos
préprandiais,
2h
após
refeições
ao
deitar.1
,
Diabetes Care,
Journal Year:
2022,
Volume and Issue:
45(9), P. 1943 - 1952
Published: July 26, 2022
Lifestyle
intervention
is
recommended
as
first-line
treatment
of
diabetes
at
all
ages;
however,
little
known
about
the
efficacy
lifestyle
in
older
adults
with
diabetes.
We
aimed
to
determine
whether
would
improve
glycemic
control
and
age-relevant
outcomes
comorbidities.A
total
100
were
randomly
assigned
1-year
intensive
(ILI)
(diet
exercise
a
facility
transitioned
into
community-fitness
centers
homes)
or
healthy
(HL)
group.
The
primary
outcome
was
change
HbA1c.
Secondary
included
glucoregulation,
body
composition,
physical
function,
quality
life.
Changes
between
groups
analyzed
mixed-model
repeated-measures
ANCOVA
following
intention-to-treat
principle.HbA1c
improved
more
ILI
than
HL
group
(mean
±
SE
-0.8
0.1
vs.
0.1%),
associated
insulin
sensitivity
(1.2
0.2
-0.4
0.2)
disposition
(26.0
8.9
-13.0
8.4
109
min-1)
indices
(between-group
P
<
0.001
0.04).
Body
weight
visceral
fat
decreased
(-8.4
0.6
-0.3
kg,
0.001,
-261
29
-30
27
cm3,
respectively).
Physical
Performance
Test
score
increased
(2.9
-0.1
0.4,
0.001)
did
VO2peak
(2.2
0.3
-1.2
mL/kg/min,
0.001).
Strength,
gait,
36-Item
Short
Form
Survey
(SF-36)
Component
Summary
also
(all
Total
dose
by
19.8
4.4
units/day.
Adverse
events
episodes
mild
hypoglycemia
group.A
strategy
highly
successful
improving
metabolic
functional
health
CNS Neuroscience & Therapeutics,
Journal Year:
2023,
Volume and Issue:
29(S1), P. 59 - 73
Published: Jan. 4, 2023
Abstract
Background
Diabetic
cognitive
dysfunction
(DCD)
is
one
of
the
most
insidious
complications
type
2
diabetes
mellitus,
which
can
seriously
affect
ability
to
self‐monitoring
blood
glucose
and
quality
life
in
elderly.
Previous
pathological
studies
have
focused
on
neuronal
dysfunction,
characterized
by
extracellular
beta‐amyloid
deposition
intracellular
tau
hyperphosphorylation.
In
recent
years,
astrocytes
been
recognized
as
a
potential
therapeutic
target
for
important
participants
central
control
metabolism.
The
disorder
gut
microbiota
their
metabolites
linked
series
metabolic
diseases
such
mellitus.
imbalance
intestinal
flora
has
effect
promoting
occurrence
deterioration
several
diabetes‐related
complications.
Gut
microbes
drive
astrocyte
activation.
Aims
We
reviewed
progress
DCD
related
“gut
microbiota‐astrocyte”
axis
terms
peripheral
inflammation,
blood–brain
barrier
(BBB)
systemic
brain
energy
metabolism
disorders
deepen
research
explore
targets.
Conclusion
“Gut
axis,
unique
bidirectional
crosstalk
brain‐gut
mediates
intermediate
process
neurocognitive
secondary